Tekla Capital Management’s BioDelivery Sciences International, Inc. BDSI Stock Holding History

Tekla Capital Management’s Portfolio BDSI Stock Details BDSI Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2015 Q4	–	Sell	-250,000	Closed	-$1.39M	–	169
2015 Q3	$1.39M	Hold	250,000	–	–	0.05%	149
2015 Q2	$1.99M	Hold	250,000	–	–	0.07%	98
2015 Q1	$2.63M	Sell	250,000 -33,411	-12%	-$456K	0.1%	104
2014 Q4	$3.41M	Sell	283,411 -218,142	-43%	-$3.31M	0.16%	79
2014 Q3	$8.57M	Hold	501,553	–	–	0.4%	51
2014 Q2	$6.05M	Sell	501,553 -181,707	-27%	-$1.72M	0.56%	45
2014 Q1	$5.77M	Buy	683,260 +101,400	+17%	+$818K	0.58%	42
2013 Q4	$3.43M	Buy	+581,860	New	+$3M	0.36%	45

Other funds holding BDSI

Broadfin Capital New York $747M AUM 100.56% 1-Year Est. Return

Federated Hermes Pittsburgh, Pennsylvania $61.5B AUM 30.7% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

FPC

Falcon Point Capital San Francisco, California $11.9M AUM 55.76% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Royce & Associates New York $10.1B AUM 42.88% 1-Year Est. Return

BIT

BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return

PCM

Penn Capital Management Philadelphia, Pennsylvania $1.29B AUM 53.44% 1-Year Est. Return

Tekla Capital Management's BDSI Position: Q4 2015 in Review

Tekla Capital Management sold out of BioDelivery Sciences International, Inc. (BDSI) in Q4 2015, closing a stake of 250,000 shares — an estimated $1.39M sold.

Tekla Capital Management first reported a position in BDSI in Q4 2013 and held it in 8 quarters. The position peaked at $8.57M in Q3 2014. 126 funds tracked by Wall St. Rank hold BDSI as of Q4 2015.

Tekla Capital Management reported no remaining BioDelivery Sciences International, Inc. position as of Q4 2015 after selling out during the quarter.
Tekla Capital Management sold 250,000 BioDelivery Sciences International, Inc. shares in Q4 2015, an estimated $1.39M.
Tekla Capital Management first reported a position in BioDelivery Sciences International, Inc. in Q4 2013 and held it in 8 quarters.
Tekla Capital Management's BioDelivery Sciences International, Inc. position peaked at $8.57M in Q3 2014.
126 funds tracked by Wall St. Rank held BioDelivery Sciences International, Inc. as of Q4 2015.

Based on Tekla Capital Management's 13F filing for Q4 2015, filed 9 Feb 2016.